Intrauterine contraception among postpartum women in Uganda
- Conditions
- Fertility-female
- Registration Number
- PACTR201910683607569
- Lead Sponsor
- Makerere Unversity
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Female
- Target Recruitment
- 232
•Postpartum women who will be willing to be followed up and give informed consent
•Intrapartum chorioamnionitis (defined as maternal fever >100.4 and two of the following conditions: Maternal leukocytosis (greater than 15,000 cells/cubic millimeter), Maternal tachycardia (greater than 100 beats/minute), Fetal tachycardia (greater than 160 beats/minute), Uterine tenderness, Foul odor of the amniotic fluid
•Postpartum Hemorrhage (defined as >500cc EBL for spontaneous vaginal delivery or >1000cc for cesarean delivery)
•Congenital or acquired uterine anomaly including fibroids if they distort the uterine cavity
•Acute liver disease or liver tumor
•Hypersensitivity to any component of the product
•Known or suspected carcinoma of the breast
•Current breast cancer or breast cancer within the past 5 years
•Decompensated cirrhosis or a liver tumor
•Known or suspected uterine or cervical neoplasia or unresolved, abnormal pap smear
•Unexplained vaginal bleeding prior to pregnancy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method